Shana Trostel
0000-0002-5929-2576
6 papers found
Refreshing results…
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer
Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity
Missing publications? Search for publications with a matching author name.